Dianalitics
Kforce Inc.
KFRC · v2 · 2026-09-15
hourglass
Loading…
Preparing the latest DD data, styles and content.
72OpportunityDD: Sep 15, 2026Analyst: 78
paidPrice at analysis date
USD 51.2 (15/09/2026)
domainMkt cap
$860M
pie_chartShares
16.77M
candlestick_chart52W
$24.49-$61.68
trending_downShort interest
4.5%
INFONYSEProfessional Staffing — Technology & FA1600 employeesFounded 1962
Verdict: Moderately Attractive

Quality small-cap staffing name emerging from 2025 cyclical trough. Q2 2026 marks inflection: EPS +24% YoY, gross margin +140bp, guidance raised. ROE 24.9% / ROIC 17.8% top-quartile among peers. Modest +13% upside to base FV $58; cyclical exposure and 18.5x forward P/E (above peer median) limit asymmetry after the +30% June-to-September rally.

📊 DIANALITICS RESEARCH INDEX Company & Thesis Assessment Score /100 — updated 2026-09-15
78
Kforce Inc. (KFRC)
Staffing & Employment Services · Industrials · NYSE · Tampa (FL)
"Quality staffing at reasonable valuation; cyclical exposure caps the upside asymmetry."
ROE 24.9% Div. yield 3.1% Q2 EPS +24% YoY Fwd P/E 18.5x Credit facility ↑ $107M
Fin. strength
15
/20 pts
EBITDA/FCF
12
/15 pts
Debt/leverage
12
/15 pts
Stage/business
13
/15 pts
Catalysts
6
/10 pts
Reg. risk
7
/8 pts
Risk/reward
5
/7 pts
Management
4
/5 pts
Sector/macro
2
/3 pts
Compliance
2
/2 pts
💡 Fair Value estimate — Segment SotP + EV/EBIT peer-derived multiples · Cross-check forward P/E
Fair value base case
USD 58.0
Range: USD 42.0-USD 72.0
Price at analysis date: USD 51.2 (15/09/2026)
Base upside/downside: +13%

Segment SotP EV/EBIT is the primary method; forward P/E cross-check reconciles within 0.4%. Implied FY27E EV/EBITDA = 9.6x, top of peer range (median 8.0x) but justified by 24.9% ROE vs peer median 12.6% and IT-staffing premium. Sensitivity analysis: ±1x on Tech EV/EBIT multiple = ±$4.5/sh (±8%). Bear-case includes ~15x forward on trough EPS as full-cycle floor. Consensus target $60.67 (Baird $63, UBS $59, Truist $60 — all raised post Q2 print). ⚠️ Not investment advice.

ComponentAssumptionUSD/share
Technology segment EVFY27E rev $1.15B × 6.5% EBIT margin × 8.5x EV/EBIT ÷ 16.6M sh (peer median 8.0x + 0.5x quality prem.)+38.3
Finance & Accounting EVFY27E rev $195M × 5.0% EBIT margin × 7.0x EV/EBIT ÷ 16.6M sh+4.1
Corporate + working capital float$10M steady-state × 8x ÷ 16.6M sh (efficiency float)+4.8
Cash & investments$22M Q2 2026 balance ÷ 16.77M shares+1.3
Net debt (credit facility)−$107.1M revolver drawdown ÷ 16.77M shares−6.4
2Y capital return NPV$1.60/sh × 2 dividends + $30M buyback NPV @9% ÷ 16.6M+5.0
Recession-scenario haircut−10% haircut on Tech EV (25% probability weight of cyclical downturn already in multiple; residual only)−4.5
FV base caseSum: 38.3 + 4.1 + 4.8 + 1.3 − 6.4 + 5.0 − 4.5≈ $58.0
Bull
$72
Probability: 20%
GenAI enterprise buildout drives Tech staffing revenue +12% in FY27; GM expands to 30%+; FY27E EPS $4.10 × 17.5x forward. Recession avoided, aggressive buyback resumes.
Base
$58
Probability: 55%
Sequential Q3/Q4 recovery per guidance (EPS $0.71–0.79 midpoint); FY26E EPS $2.75, FY27E $3.30 (+20% YoY). 17.5x multiple, dividend + buyback maintained.
Bear
$42
Probability: 25%
US recession / IT hiring freeze in H1 2027; staffing revenue −8/−10%; FY27E EPS compresses to $2.30 × 15x cyclical trough multiple. Credit facility usage rises, buyback paused.
Methodology: Segment SotP EV/EBIT is the primary method; forward P/E cross-check reconciles within 0.4%. Implied FY27E EV/EBITDA = 9.6x, top of peer range (median 8.0x) but justified by 24.9% ROE vs peer median 12.6% and IT-staffing premium. Sensitivity analysis: ±1x on Tech EV/EBIT multiple = ±$4.5/sh (±8%). Bear-case includes ~15x forward on trough EPS as full-cycle floor. Consensus target $60.67 (Baird $63, UBS $59, Truist $60 — all raised post Q2 print). ⚠️ Not investment advice. Not investment advice.
The DD legitimately concludes the stock is "modestly attractive" rather than "deep value" after the recent rerating.
📊 Capital Structure · Short Interest · Buyback & Dilution
🟢 Short Interest
~4.5%
~750k shares of 16.77M outstanding; ~3 days to cover. No active short-seller thesis identified — consensus reads KFRC as a stable-quality mature staffing name rather than a directional bet.
🟢 Share dilution (1Y)
−1.5%
16.77M shares out (Sep 2026) vs 17.03M YoY. Net buyback accretive: 527k shares repurchased H1 2026 at avg $27.90/sh, net of RSU issuance. Cumulative capital returned crossed $1B in 2026.
🟢 Buyback + Dividend
$27M H1
H1 2026: $14.7M open-market buyback + $13.5M dividends. Annual dividend $1.60/sh raised 3% YoY (3.12% yield). Payout ratio ~55% of FY26E EPS — well covered by FCF.
Short Interest — context
KFRC — 4.5%
4.5%

Low SI (<5%) = no squeeze setup, no short-driven thesis. Insider transactions (12M): only routine RSU vesting + tax withholding by CEO Liberatore (19,302 shares withheld at $31.41 for taxes on 49,060 vested RSUs in Jan 2026). No material open-market insider selling (>$500K) identified. Insider alignment intact.

$Financial analysis — FY 2026 in progress
Market cap
$860M
Small cap ($300M–$2B range)
Revenue TTM
$1.34B
−1.3% YoY (bottoming)
ROE / ROIC
24.9%
Top quartile vs peers
Fwd P/E
18.5x
Peer median 14.6x
ItemFY23FY24FY25FY26EGuidance FY26 / FY27E
Revenue ($M)1,5221,4111,3351,3951,485 (FY27E)
Gross margin %28.1%27.6%27.9%28.7%29.2% (FY27E)
Operating income ($M)75.862.550.272.085.0 (FY27E)
Net income ($M)52.750.434.846.054.0 (FY27E)
Diluted EPS ($)2.822.682.122.753.30 (FY27E)
Free cash flow ($M)6555425065 (FY27E)
FY25 = trough year (revenue −5.4%, EPS −31%). FY26E reflects Q1+Q2 actuals ($330M + $349M) + midpoint of Q3 guide ($353M) + Q4 seasonal estimate. FY27E consensus $3.00–3.30, midpoint used.
Quarterly dynamics — last 5 quarters
MetricQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Revenue ($M)334.2340.1331.0330.4349.3
Gross margin %27.127.427.828.028.5
Diluted EPS ($)0.590.530.470.460.73
End-of-period cash ($M)18.121.019.522.522.0
Credit facility balance ($M)75.085.090.098.5107.1
Financial position and sustainability
Net leverage (debt/EBITDA)
~1.1x
Dividend payout ratio (FY26E)
~58%
Interest coverage
~12x
account_tree

Business model — US professional staffing (Technology-heavy)

Two-segment US-only staffing firm with IT-consulting overlay
Kforce (IPO 1995, Tampa FL, ~1,600 employees) places contract and direct-hire professionals in Technology (systems, cloud, data, AI/ML, cybersecurity — ~87% of revenue) and Finance & Accounting (~13%). Client base diversified across financial services, healthcare, government contractors, telecom; top-10 concentration ~25%. Revenue mix ~85% recurring temporary/contract + ~15% direct-hire (higher margin, more cyclical). Strategic pivot in progress toward Kforce Solutions / consulting engagements to lift margin structure and reduce pure staff-augmentation exposure.

Technology staffing & solutions ~$1.21B FY26E (87% rev) 🟢 recovering IT contract + consulting: cloud, data, AI/ML, cybersecurity. Bill rates $90–140/hr avg. Q2 2026 GM 28.9%, consultant headcount +2.6% YoY. Key risk: enterprise IT budget cuts in recession; opportunity: GenAI implementation demand + Kforce Solutions expansion. Finance & Accounting ~$185M FY26E (13% rev) 🟡 stabilizing Contract + direct-hire in accounting/finance. Bill rates $50–70/hr. Q2 2026 GM ~25%. Lower growth ceiling but historical downturn hedge as clients flex to variable finance staff. Steady recurring revenue base. Consulting / Kforce Solutions Embedded in Tech 🟢 mix-shift Managed solutions / project-based delivery. Reported inside Technology segment. Strategic priority: management targets increasing share of higher-margin (35%+ GM) engagements. Multi-year re-rating catalyst if execution delivers.

gavel

Legal, regulatory and risk analysis

Cyclicality of staffing revenue
Moderate
US staffing tracks GDP and IT capex closely. In prior recessions (2008, 2020) revenue dropped 15–20%. If US labor market softens materially in H1 2027, KFRC would see rapid volume & bill-rate pressure.
AI substitution risk
High
Enterprise GenAI may compress demand for junior/mid IT staffing over 2027–2029; bill-rate risk on commodity IT roles. Counter: near-term AI implementation projects drive incremental demand for senior consultants (KFRC's higher-margin mix).
Client concentration
Moderate
Top-10 clients ~25% of revenue with financial services heavy weight. Loss of a top-5 client would hit growth 3–5%. Some FS clients cyclical themselves — correlated risk.
Credit facility usage rising
Moderate
Revolver balance up from $75M (Q2'25) to $107M (Q2'26). Not covenant-critical (net leverage still ~1.1x) but constrains buyback pace. Trend to monitor: another $30M draw and management may pause repurchases.
Balance sheet resilience
Low
Net debt only ~1.1x EBITDA. $22M cash + $250M+ facility headroom. Dividend well-covered (~58% payout on FY26E EPS). Interest coverage ~12x. No refinancing risk near term.
Capital return discipline
Positive
$1B+ cumulative dividends + buybacks over the past decade. Dividend raised 3% in 2026 (12+ years of consistent increases). Management increases repurchases when the stock trades below intrinsic value — pattern of value-accretive capital allocation.
Quality metrics
Positive
24.9% ROE, 17.8% ROIC — top quartile among staffing peers (median 12.6%). Beta 0.88 (below-market volatility). Long-tenured management (CEO Liberatore has extensive KFRC tenure). Consistent execution track record.
Legal / regulatory
Low
Legacy California employment class actions on recruiter exempt classification (Cook/Pratt 2022) — typical for staffing industry, manageable reserves. No active SEC investigations, no short-seller reports, no shelf registration signals identified in last 12 months.
article

SWOT analysis

Strengths
  • +IT-heavy revenue mix (~87%) = higher bill rates and stickier client relationships vs peers
  • +24.9% ROE / 17.8% ROIC — top-quartile capital efficiency in the staffing industry
  • +$1B+ cumulative capital returned; consistent 12-year dividend growth streak
  • +Q2 2026 inflection: EPS +24% YoY, GM +140bp, Baird / UBS / Truist all raised targets
Weaknesses
  • FY25 revenue −5.4% and EPS −31%: cyclical trough scars still visible in TTM metrics
  • US-only footprint: no international diversification, structural growth ceiling
  • Credit facility drawdown accelerating (+$32M YoY); H1 FCF slightly negative
  • Client concentration ~25% top-10; heavy financial-services exposure adds cyclical beta
Opportunities
  • GenAI enterprise buildout drives IT consulting demand acceleration into FY27
  • Consulting / Kforce Solutions mix shift lifts blended gross margin structurally
  • Sequential bill-rate + GM recovery (Q2 GM +140bp) = margin inflection continues in H2
  • Analyst momentum: Baird target $63 (from $42), UBS $59, Truist $60, consensus $60.67
Threats
  • !US labor market softening / hiring freezes: staffing revenue compression risk
  • !AI substitution for lower-end staffing roles (bill rate + volume risk medium-term)
  • !Peer valuation compression: staffing EV/EBITDA range historically 4–11x
  • !Tariff / macro shocks disrupting client capex decisions in tech and financial services
article

Summary by assessment area

🎯 Investment thesis — Moderate
  • Small-cap quality staffing name emerging from 2025 cyclical trough
  • Q2 2026 inflection confirmed: EPS +24% YoY, GM +140bp, guidance raised
  • Forward P/E 18.5x above peer median 14.6x — quality premium partly justified
  • Base FV $58 = +13% upside; +40% bull if GenAI-driven Tech acceleration
⚠️ Key risks — Moderate
  • Cyclical staffing exposure to US GDP and IT capex (historical −15/−20% in recessions)
  • AI substitution risk on junior/mid IT staffing roles medium-term
  • Credit facility usage $107M (from $75M YoY) constrains aggressive buyback pace
  • Bear scenario: FY27E EPS $2.30 × 15x = $42 FV (−18% from spot)
🔑 Catalysts to watch — Moderate
  • Q3 2026 earnings 2026-11-02: guided EPS $0.71–0.79 vs consensus $0.70
  • US labor market prints (nonfarm payrolls, IT capex indicators)
  • Buyback pace vs credit facility drawdown = management conviction signal
  • FY27 outlook at Q4 2026 print (Feb 2027) — sets the re-rating anchor
Sources & Disclaimer

Sources: StockAnalysis.com (KFRC overview, price history, statistics — accessed 2026-09-15); Kforce Q2 2026 earnings release & 10-Q (Businesswire / SEC EDGAR, 2026-07-27); TheFly analyst notes (Baird target $63 raised from $42 on 2026-08-25; UBS $59; Truist $60); Zacks Industry Outlook (staffing industry EV/EBITDA 7.34x); Yahoo Finance; Investing.com; SEC Form 4 filings (Kforce CEO Liberatore, Jan 2026). Market data — last verified close 2026-09-11: KFRC ~$51.24, market cap ~$860M, 52W: $24.49–$61.68, shares outstanding 16.77M. Short interest ~4.5%. Q2 2026 balance sheet: cash $22.0M, credit facility $107.1M, net debt ~$85M. Consensus PT $60.67 (5 analysts, Buy, as of 2026-09-12). This document is for informational purposes only and does not constitute financial or investment advice.